40
CHEMOTHERAPY HIGHLIGHTS MOHAMED BAHR; MD, PHD Anticancer Drugs

Chemotherapy 7 anticancer agents

Embed Size (px)

Citation preview

Page 1: Chemotherapy 7 anticancer agents

CHEMOTHERAPYHIGHLIGHTS

MOHAMED BAHR; MD, PHD

Anticancer Drugs

Page 2: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

CANCER CHEMOTHERAPY

Page 3: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 4: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 5: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 6: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 7: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

I. ALKYLATING AGENTS (CCNS)Cyclophosphamide, Busulphan – Nitrosoureas – Cisplatin.

They are chemical substances containing highly reactive

groups (alkyl). They transfer these active groups to various

cellular constituents, mainly DNA, proteins and enzymes

decreasing their synthesis and/ or function.

Page 8: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 9: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

II. ANTIMETABOLITES (S PHASE)They are structural analogs of naturally occurring metabolites

competing with them for enzyme systems → ↓ DNA and RNA

synthesis.

A. 6- Mercaptopurine (purine antagonist)

Decreases purine synthesis → ↓ DNA and RNA synthesis.

B. Methotrexate (folic acid antagonist)

Inhibits DHFR → ↓ H4F synthesis → ↓ DNA and RNA synthesis.

Page 10: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 11: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 12: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

III. NATURAL PRODUCTSA. Plant alkaloids: (Vinblastine, Vincristine) (M phase)

They are mitotic spindle poisons → mitotic arrest.

Page 13: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 14: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 15: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

B. Antibiotics

Bind to DNA → fragmentation of its strands → ↓ DNA

synthesis.

Bleomycin (G2 - M)

Dactinomycin - Adriamycin - Mitomycin - Doxorubicin (CCNS)

Page 16: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 17: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 18: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 19: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

C. Camptothecins (topoisomerase I inhibitors) (CCNS)

Irinotecan - Topotecan

Page 20: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 21: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 22: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

D. Epipodophyllotoxin (topoisomerase II inhibitor) (G1–S

phase)

Etoposide

Page 23: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 24: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 25: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

E. Taxanes (M phase)

Paclitaxel

Page 26: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 27: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 28: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

F. Enzymes (L- asparaginase)

↓ Blood asparagine → deprives tumor cells of this amino acid

which is essential for protein synthesis.

Page 29: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 30: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 31: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

G. Interferons

See Before

Page 32: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

IV. HORMONES AND ANTAGONISTSCorticosteroids in leukemia and lymphomas.

Testosterone in cancer breast.

Estrogen in cancer prostate.

Hormone receptors agonists and antagonists:

(estrogen/tamoxifen), (testosterone/cyproterone, flutamide).

GnRH agonists (leuprolide and goserelin) for prostate and

breast tumors.

Page 33: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 34: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 35: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 36: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

V. MISCProtein tyrosine kinase inhibitors: Imatinib

Immunomodulators: Thalidomide

Page 37: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

ADVERSE EFFECTSA. GENERALBone marrow depression: leucopenia, thrombocytopenia or pancytopenia.

Hair loss.

GIT disturbances: vomiting, diarrhea and GIT ulcers.

Hyperuricemia (due to destruction of ↑number of tumor cells).

Immunosuppression: liability to infections and delayed healing of wounds.

Gonadal damage: sterility, amenorrhea and azospermia.

Teratogenicity and mutagenicity.

Secondary malignancy.

Page 38: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

Page 39: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

B. SPECIFICCyclophosphamide: hemorrhagic cystitis.

Busulphan: interstitial pneumonitis and pulmonary fibrosis.

Methotrexate: hepatotoxic, nephrotoxic, neurotoxic & folate

deficiency

Vinca alkaloids: peripheral and autonomic neuropathy.

Bleomycin: pulmonary fibrosis – skin pigmentation.

Page 40: Chemotherapy 7 anticancer agents

Mohamed Bahr; MD, PhD

REFERENCESLippincott’s Illustrated Reviews, 5th ed.

Color Atlas of Pharmacology, 2nd ed.

Goodman and Gilman's The Pharmacological Basis of

Therapeutics, 12th ed.